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Monoclonal antibodies have been prepared against rat liver epoxide hydrolase (EH), some of which gave 
pr~pitation lines on immun~iffusion against pure EH su~esting the presence of repetitive structural 
domains on the enzyme. Using ELISA, with polyclonal antibodies to rat and rabbit liver EH, reactivity 
and therefore structural similarities between EH of all species tested, including human, were observed. 
This was in contrast o immunodiffusion results demonstrating the limitations of the latter technique. 
Using monoclonal antibodies in ELISA, greatest ructural similarity was between rat, mouse, and Syrian 
hamster EH and relatively little between rat and human. Two of the antibodies reacted with nearly all 
species tested and may be directed towards critical sites on the enzyme. This and most of the EH molecule 
would appear to be localised on the cytoplasmic surface of the endoplasmic reticulum, 
Epoxide hydrolase Monoclonal antibody Protein structure 
Enzyme-linked immunosorbent assay 
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1, INTRODUCTION 
Liver microsomal epoxide hydrolase has been in- 
vestigated extensively over. the past few years 
because of its important role in the disposition of 
toxic and/or carcinogenic epoxides [l]. This ubi- 
quitous enzyme has been shown to be present in 
most of the organs [Z] of many different animal 
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Abbreviations: ELISA, enzyme-linked immunosorbent 
assay; BSA, bovine serum albumin; IgG, immunoy- 
globulin; ABTS, 2,2-azino-bis-(3-ethyl)-benzothiozolin- 
Q-sulphonic acid; i.p., intraperitoneal; PVC, polyvinyl- 
chloride 
species [3]. The enzyme has been purified in several 
laboratories [4-71 and some studies have 
demonstrated structural and catalytic similarities 
between the enzyme isolated from the rat and that 
found in human liver [7-121. The extent of struc- 
tural analogy between the rat enzyme to that pre- 
sent in species other than human has been limited 
to immunochemical cross-reactivity measured by 
immunodiffusion. The recent development of 
enzyme-linked i~unosorbent assays @LISA), 
together with the ability to make, site-specific, 
monoclonal antibodies has greatly enhanced the 
potential of antibodies as structural probes. Here, 
we have used these techniques to investigate and 
compare the structure and localization of epoxide 
hydrolase in hepatic microsomes and cytoso1 
prepared from various animal species. Most of the 
polyclonal antibodies obtained to date were not in- 
hibitory to epoxide hydrolase. The possibility that 
some monoclonal antibodies may be effective in- 
hibitors was also tested. 
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2. MATERIALS AND METHODS 
Hepatic mi~rosomal and cytosolic fractions were 
prepared from male animals of the following 
species: Sprague Dawley rats (200 g), ZEl mice 
(25 g), New Zealand White rabbits (2.5 kg, inbred 
strain), guinea pigs (300 g), Syrian hamsters 
(100 g) and Chinese hamsters (40 g). 
In addition microsomes were prepared from 
monkey liver and human liver samples. Epoxide 
hydrolase from rat liver was purified to apparent 
homogeneity by the method of Bentley and Oesch 
141. Rabbit liver epoxide hydrolase was purified to 
apparent homogeneity by the method of Timms, 
Guenthner and Oesch (in pre~ration). Polyclonal 
antisera to these proteins were raised in goats 1131. 
Monoclonal antibodies to rat liver epoxide hydrol- 
ase were prepared from mice using standard 
methods summarized by Burger et al. [14]. Anti- 
body-secreting cells were injected i.p. into BALB/c 
mice and the induced ascites fluid collected and 
stored in aliquots at - 70°C. ELISA tests were car- 
ried out using conventional procedures [15]. Con- 
trol samples for each determination using pre- 
immune IgG or an unrelated monoclonal antibody 
were run. Epoxide hydrolase activity was measured 
using styrene oxide as substrate as reported in [16] 
but in the absence of Tween-80 as described in 
detail f8], one unit of activity being the amount of 
enzyme required to hydrate 1 nmol styrene ox- 
ide/min [4]. The inhibition of the epoxide hydrol- 
ase activity by the monoclonal or polyclonal anti- 
bodies was investigated by incubating the pure 
enzyme (4 units) with 25 pl of the concentrated 
culture medium from cells secreting antibody or 
with the ascites fluid diluted 1: 10 (25 /rl) or with 
polyclonal IgG (25 ~1, stock 10 mg/ml) for 30 min 
at 4% prior to the addition of the assay buffer and 
the [‘H]styrene oxide substrate [16]. Control in- 
cubations were run using culture medium, control 
ascites or control IgG. 
Double immunodiffusion analysis was run by 
the Ouchterlony method [17]. Where microsomal 
samples were used, the protein was first solubilized 
with sodium cholate (1 mg/2 mg protein). A 5 ~1 
solution containing 10 units of epoxide hydrolase 
was used per well. The IgG concentration was 
10 mg/ml (5 ~1). The 1% agarose gels contained 
0.2% Emulgen 911. Protein was determined by the 
Lowry method [18]. 
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Peroxidase-conjugated, anti-goat IgG in rabbit 
and peroxidase-conjugated, anti-mouse IgG in 
rabbit were from Dynatech ~lo~hingen). Freund’s 
adjuvants were from Difco Labs Heidelberg), 
ABTS was from Serva (Heidelberg) and 
polyethylene glycol 4000 was from Merck (Darm- 
stadt). [3H]Styrene oxide was synthesized as in 
[16]. All other chemicals were obtained from com- 
mercial sources. 
3. RESULTS AND DISCUSSION 
Monoclonal antibodies were produced against 
rat liver microsomal epoxide hydrolase. ELISA- 
positive clones (24) were selected for further in- 
vestigation. The antibodies produced by all of the 
clones were tested by immuno~ffusion against he 
pure enzyme and 4 of these antibodies gave 
precipitation lines: MZ-FC4, MZ-JC3, MZ-DG2 
and MZ-HC3, 3 of which are shown in fig.1. 
Precipitation of a molecule by a single monoclonal 
antibody, in contrast to conventional antisera, re- 
quires the presence of repetitive determinants or 
structurally similar molecular domains on the an- 
tigen. This suggests the presence of repeating struc- 
tural domains on the epoxide hydrolase molecule. 
Verification is needed as to whether this is so or 
whether it is an artifact. The fact that only 4 of the 
reactive antibodies gave precipitin lines, tends to 
Fig. 1. Ouchterlony analysis of monoclonal antibodies to 
rat liver epoxide hydrolase. The centre wells contained 
1Opg epoxide hydrolase. The other wells contained the 
following ascites samples: (1) MZ-AD3 (clone Bs); (2) 
MZ-AD3 (clone GE); (3) MZ-FC4 (clone BI); (4) MZ- 
FC4 (clone Bs); (5) MZ-JC3 (clone El); (6) buffer; (7) 
MZ-HC3 (clone Bs); (8) MZ-HC3 (clone Dr); (9) MZ- 
JC3 (clone B5); (10) MZ-JC3 (clone Crr); (11) buffer; 
(12) buffer. 
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rule out artifacts associated with the analysis pro- 
cedure. Whether these regions are important in the 
catalytic activity of the enzyme is under investiga- 
tion. The hepatic microsomal epoxide hydrolase 
activity in the various animal species used in this 
study is shown in fig.2. Styrene oxide was used as 
a representative substrate of microsomal epoxide 
hydrolase activity. As observed in previous studies 
[3], the mouse had the lowest microsomal epoxide 
hydrolase activity and the highest value was 
measured in the human sample which was 25fold 
higher than in the mouse. 
Various assays were used to compare the extent 
of structural analogy between the microsomal and 
cytosolic epoxide hydrolases present in different 
species, immunodiffusion, ELISA and mono- 
clonal antibodies. In the first instance, the reactivi- 
ty of conventional antisera prepared by immuniza- 
tion of goats with rat or rabbit epoxide hydrolase 
was tested against enzyme from various species by 
immunodiffusion. The antiserum to the rat en- 
zyme showed marked reactivity and gave lines of 
identity with solubilized microsomes from rat, 
mouse and Syrian hamster. Reactivity was also 
observed with guinea pig microsomes, however a 
line of identity was not obtained. No reactivity was 
observed with the primate, rabbit, Chinese hamster 
or human microsomes. A lack of reactivity with 
human epoxide hydrolase has been reported by Lu 
and Levin et al. [19,20]. However, Guengerich et 
Fig.2. Epoxide hydrolase activity in liver microsomal 
samples prepared from various animal species using 
styrene oxide as substrate: Rab, rabbit; M, mouse; Hu, 
human; G.Ham, golden hamster; C.Ham, Chinese 
hamster; G.Pig, guinea pig. Experimental conditions are 
referred to in section 2. 
al. [lo] have reported immunochemical similarities 
between these enzymes. Antibodies to the purified 
rabbit enzyme only reacted with the purified an- 
tigen and rabbit liver microsomes. On the basis of 
the above data, there are significant differences 
between the structure of various epoxide hy- 
drolases. 
The antibody to the rat enzyme also reacted with 
cytosolic fractions from the rat and also from the 
Syrian hamster and mouse (not shown). The rabbit 
antibody did not react with any of the cytosol frac- 
tions. Experiments are in progress to determine 
whether this reaction is with cytosolic epoxide 
hydrolases. The cytosol used did not hydrate 
styrene oxide at a detectable level so it is unlikely 
that the reactivity was due to microsomal con- 
tamination. In [21] we could not detect any reac- 
tivity of an antibody to microsomal epoxide 
hydrolase with the cytosolic fraction. This anoma- 
ly may be explained in that a different antibody 
preparation was used here. Wang et al. [22] have 
shown that antibodies to human liver microsomal 
epoxide hydrolase react with a form of the cyto- 
solic enzyme. ELISA is an extremely sensitive 
assay and was used here as an alternative method 
for investigating structural analogy between 
epoxide hydrolases. A calibration curve of the ex- 
tent of antibody binding against the concentration 
of rat epoxide hydrolase present was linear for 
solutions containing up to 2.5 pg epoxide 
hydrolase/ml (1.3 units/ml), after which con- 
centration some deviation from linearity was 
observed. The detection limit was for solutions of 
approximately 0.1 gg/ml. Both rat and rabbit anti- 
bodies reacted in ELISA with all the species tested 
(table l), indicating antigenic and therefore struc- 
tural analogy between all epoxide hydrolases, and 
demonstrating that they may originate from a 
common ancestral gene. These data are not in 
agreement with the immunodiffusion results 
presented here and those of other workers. This is 
probably due to the higher sensitivity of ELISA 
compared with Ouchterlony analysis, and care 
should be taken when immunodiffusion assays are 
used as the sole evidence for lack of structural 
similarities. The finding that epoxide hydrolase 
can be precipitated by a single monoclonal anti- 
body shows that immunodiffusion is also a poor 
method for demonstrating extensive structural 
similarities and is exemplified here by the reactivity 
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Table 1 
Comparison of the reactivity of polyclonal antibodies to rat or rabbit epoxide hydrolase with liver microsomes from 
various animal species 
Rat EH Rabbit Rat Rabbit Human Ape Guinea Hamster Hamster Mouse 
(1 unit) EH (0.5 pi8 (Syrian) (Chinese) 
units) 
Anti-rat 
- cholate 0.32 0.08 0.29 0.20 0.15 0.18 0.12 0.24 0.27 0.26 
+ cholate 0.27 0.05 0.44 0.19 0.16 0.16 0.11 0.14 0.01 0.07 
Anti-rabbit 
- cholate 0.08 0.55 0.21 1.15 0.08 0.22 0.33 0.13 0.07 0.05 
+ cholate 0.17 0.61 0.13 1.20 0.08 0.24 0.33 0.13 0.11 0.08 
The stock solutions were: antibodies, 0.01 mg IgG/ml, microsomes containing about 2 ,ug epoxide hydrolase (1 unit). 
Solubilization was with 0.16% sodium cholate (+ cholate). Other details are given in [IS]. Rat EH and rabbit EH are 
the purified enzymes. The experiment was repeated 3 times with similar results 
of antibodies to the rat enzyme with guinea pig 
microsomes on Ouchterlony analysis but a low 
level of reactivity on ELISA. This is substantiated 
by the data obtained using monoclonal antibodies 
(see later). The extent of reactivity in the ELISA 
run at constant units of epoxide hydrolase varied 
with the species and is a measure of differences 
either in enzyme structure or in the accessibility of 
the antigen in the microsomal membrane. The lat- 
ter possibility can be essentially ruled out because 
in the majority of cases solubilization of the 
microsomal membrane did not lead to a change in 
the extent of reaction. In some instances, for ex- 
ample with the rat, the interaction increased (table 
l), indicating the exposure of buried antigenic sites 
by the solubilization procedure. In some cases, 
cholate caused a decrease in the peroxidase reac- 
tion; the reason for this is unclear. The extent of 
reaction in ELISA using the rat antibody indicated 
most structural similarity between the rat, mouse 
and Syrian hamster enzymes. By this criterion, 
these 3 proteins appear to be extremely similar. 
The largest differences from the rat were with the 
primate, human and guinea pig enzymes. The rab- 
bit only reacted well with the rabbit enzyme and 
rabbit liver microsomes; however, it would appear 
to have most structural similarity with the guinea 
pig and least with the human enzymes. The rabbit 
antibody reacted poorly with the rat enzyme. 
However, the rat antibody reacted well with the 
rabbit enzyme, demonstrating similarities but 
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possibly some significant structural differences. 
The low reactivity of the rabbit antibody with rat, 
mouse and hamster microsomes would be in agree- 
ment with the structural similarity between the lat- 
ter proteins. The 13 monoclonal antibodies to the 
rat epoxide hyclrolase with the highest titre were 
checked for reactivity with hepatic microsomes 
from various animal species (table 2). The experi- 
ment was repeated three times with the same 
results. A reaction was considered positive if the 
value obtained was 150% of a control sample run 
with a monoclonal antibody from another source. 
The number of reacting antibodies depended on 
the species tested. The highest number of positive 
reactions was with the Syrian hamster and mouse 
microsomal preparations, in agreement with the 
results using the polyclonal antibodies. That not all 
antibodies were positive suggests certain dif- 
ferences between these and the rat enzymes. Only 
a few of the antibodies reacted with guinea pig, ape 
or human microsomes. This is in contrast to 
various reports of extensive structural analogy of 
the rat with the human enzymes [7,10,11]. In [8] 
we demonstrated close similarities in structure- 
activity relationships between epoxide hydrolase in 
rat and man. Whether the monoclonal antibodies 
which react with both the rat and human enzymes 
are related to the catalytic properties of the en- 
zymes remains to be investigated. The pattern of 
reactivity against he epoxide hydrolases of various 
species gives an indication of whether the anti- 
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Table 2 
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Liver microsomal samples from the species shown above containing 10 units of epoxide hydrolase/mI were used. Of 
this solution, 20 ~1 was taken per assay. Other details are given in section 2 
bodies used are to different antigenic sites. For microsomes with sodium cholate or Emulgen 911, 
example, it is conceivable that clones MZ-AD3 and the reactivity of the antibodies was essentially 
MZ-BD9 are the same antibody (table 2). unaltered (in some cases an inhibition of reactivity 
However, by this criterion most of the antibodies was measured) which suggests that a large propor- 
used appear to be to different antigenic sites. tion of the epoxide hydrolase molecule is exposed 
The data shown in table 2 were obtained with in- on the membrane surface. This finding is confirm- 
tact microsomal vesicles. On solubilization of the ed by the data in table 1. 
Table 3 















MZ-JB2 I .40 99 MZ-DD 11 0.89 63 
MZ-AD3 1.32 94 MZ-BD9 1.32 93 
MZ-JCIO 1.06 75 MZ-EB7 0.92 65 
MZ-HC3 1.10 79 MZ-FC4 1.16 82 
MZ-FCS 1.21 85 MZ-GG6 1.30 92 
MZ-HE3 1.10 77 MZ-HC4 0.99 70 
MZ-BG4 1.25 88 MZ-JC3 0.96 68 
MZ-JB4 1.08 76 MZ-JB3 1.23 87 
MZ-EFlO 1.40 98 MZ-JB6 1.14 80 
MZ-JB4 1.25 88 MZ-DG2 0.86 60 
MZ-HC5 1.15 81 
Epoxide hydrolase 1.42 units was incubated for 30 min at 4°C in the presence of 20 ~1 concentrated IgG-containing 
fraction from the monoclonal cell culture medium. Total volume was 200 ~1 in 0.1 M Tris-HCl (pH 8.5). Following 
incubation, ]“H]styrene oxide was added and the sample incubated for 10 min at 37°C. Other conditions were as in IS] 
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In table 3, 21 monoclonal antibodies were tested 
for their ability to inhibit the hydration of styrene 
oxide. None of the antibodies proved to be an ef- 
fective inhibitor although a few did inhibit up to 
40%. It is of interest to note that of those that did 
inhibit, MZ-DG2 and MZ-JC3 reacted in almost 
all species and gave precipitin lines on Ouchterlony 
analysis. These antibodies may be directed at 
determinants located on critical sites of the enzyme 
molecule. 
In conclusion, epoxide hydrolase may well con- 
tain repeating structural units. There are structural 
similarities between microsomal epoxide 
hydrolases of different species but also significant 
differences. As the substrate specificities of these 
enzymes are similar, the differences do not appear 
to be critical factors in determining activity, and 
the activity may be dependent on the presence of 
certain common peptides through all species. A 
large proportion of the enzyme molecule appears 
to be exposed on the cytosolic surface of the en- 
doplasmic reticulum. 
The application of monoclonal antibodies 
should prove extremely valuable in lucidating fur- 
ther the structural, functional and topographical 
aspects of this enzyme. 
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